Hideaki Nagai

4.0k total citations
125 papers, 1.7k citations indexed

About

Hideaki Nagai is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Hideaki Nagai has authored 125 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Epidemiology, 69 papers in Infectious Diseases and 39 papers in Surgery. Recurrent topics in Hideaki Nagai's work include Tuberculosis Research and Epidemiology (52 papers), Mycobacterium research and diagnosis (35 papers) and Infectious Diseases and Tuberculosis (21 papers). Hideaki Nagai is often cited by papers focused on Tuberculosis Research and Epidemiology (52 papers), Mycobacterium research and diagnosis (35 papers) and Infectious Diseases and Tuberculosis (21 papers). Hideaki Nagai collaborates with scholars based in Japan, Netherlands and United States. Hideaki Nagai's co-authors include Atsuhisa Tamura, Atsuyuki Kurashima, Hirotoshi Matsui, Harumi Shishido, Ken Ohta, Ryozo Yoneda, Eriko Yamaguchi, Masahiro Kawashima, Eisuke Matsushima and Junko Suzuki and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Hideaki Nagai

124 papers receiving 1.7k citations

Peers

Countries citing papers authored by Hideaki Nagai

Since Specialization

Citations

This map shows the geographic impact of Hideaki Nagai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Nagai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Nagai more than expected).

Fields of papers citing papers by Hideaki Nagai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideaki Nagai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Nagai. The network helps show where Hideaki Nagai may publish in the future.

Co-authorship network of co-authors of Hideaki Nagai

This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Nagai. A scholar is included among the top collaborators of Hideaki Nagai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Nagai. Hideaki Nagai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Detection of Anti-SARS-CoV-2 Nucleocapsid and Spike Antibodies in Patients with Coronavirus Disease 2019 in Japan 2022 ·SHILAP Revista de lepidopterología ·Hiroshi Furukawa, Shomi Oka, Takashi Higuchi, (unknown), (unknown), (unknown), (unknown), (unknown), Hideaki Nagai, Shigeto Tohma	2
2	Evaluation of cytokine levels in response to mitogen among HIV-1-infected blood cells and their relationships to the number of T cells 2022 ·Cytokine ·(unknown), Maho Suzukawa, Keita Takeda, (unknown), (unknown), Shigeto Tohma, Takahide Nagase, Ken Ohta, Katsuji Teruya, Hideaki Nagai	2
3	Evaluation of tuberculosis diagnostic biomarkers in immunocompromised hosts based on cytokine levels in QuantiFERON-TB Gold Plus 2022 ·Tuberculosis ·(unknown), Maho Suzukawa, Keita Takeda, (unknown), (unknown), (unknown), (unknown), Eri Nakano, (unknown), (unknown), (unknown), (unknown), Takahide Nagase, Ken Ohta, Katsuji Teruya, Hideaki Nagai	2
4	Interrupted time-series analyses of routine vaccination program for elderly pneumonia patients in Japan; an ecological study using aggregated nationwide inpatient data 2021 ·Human Vaccines & Immunotherapeutics ·Koichi Kobayashi, Taisuke Jo, (unknown), Maho Suzukawa, Nobuharu Ohshima, Goh Tanaka, Manabu Akazawa, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga, Takahide Nagase, Hideaki Nagai	2
5	Factors associated with false negative interferon-γ release assay results in patients with tuberculosis: A systematic review with meta-analysis 2020 ·Scientific Reports ·Mari Yamasue, Kosaku Komiya, (unknown), Kenji Umeki, Shin‐ichi Nureki, Masaru Ando, Kazufumi Hiramatsu, Hideaki Nagai, Jun‐ichi Kadota	43
6	A case of Mycobacterium tuberculosis laboratory cross-contamination 2019 ·Journal of Infection and Chemotherapy ·Keita Takeda, Yoshiro Murase, Masahiro Kawashima, Maho Suzukawa, Junko Suzuki, Akira Yamane, Yuriko Igarashi, Kinuyo Chikamatsu, Yuta Morishige, Akio Aono, Hiroyuki Yamada, Akiko Takaki, Atsuhisa Tamura, Hideaki Nagai, Hirotoshi Matsui, Shigeto Tohma, Satoshi Mitarai	4
7	The benefit of stool mycobacterial examination to diagnose pulmonary tuberculosis for adult and elderly patients 2019 ·Journal of Clinical Tuberculosis and Other Mycobacterial Diseases ·A Konno, Osamu Narumoto, Hirotoshi Matsui, Keita Takeda, (unknown), (unknown), Hiroyuki Tashimo, Masahiro Kawashima, Akira Yamane, Atsuhisa Tamura, Hideaki Nagai, Ken Ohta, Shigeto Tohma	4
8	Clinical and Angiographic Characteristics of 35 Patients With Cryptogenic Hemoptysis 2017 ·CHEST Journal ·Takahiro Ando, Masahiro Kawashima, Kimihiko Masuda, Keita Takeda, Kenichi Okuda, Junko Suzuki, Nobuharu Ohshima, Hirotoshi Matsui, Atsuhisa Tamura, Hideaki Nagai, Shinobu Akagawa, Ken Ohta	21
9	Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB 2016 ·Journal of Infection and Chemotherapy ·Kazunari Tsuyuguchi, Hideaki Nagai, Kenji Ogawa, Tomoshige Matsumoto, Kozo Morimoto, Akiko Takaki, Satoshi Mitarai	3
10	Nationwide HIV-, MDR-TB survey in Japan and collaborative study in the Philippines 2016 ·International Journal of Mycobacteriology ·Toshio Hattori, Nobuyuki Kobayashi, Hideaki Nagai, Haorile Chagan‐Yasutan, Elizabeth Freda O. Telan, (unknown)	8
11	Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy 2015 ·Respiratory Medicine ·Kazuya Koyama, Nobuharu Ohshima, Masahiro Kawashima, Kenichi Okuda, Ryota Sato, Hideaki Nagai, Hirotoshi Matsui, Ken Ohta	4
12	Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease 2015 ·BMC Infectious Diseases ·Tsukasa Kadota, Hirotoshi Matsui, Takashi Hirose, Junko Suzuki, Minako Saito, (unknown), Kouichi Kobayashi, (unknown), Masahiro Kawashima, Atsuhisa Tamura, Hideaki Nagai, Shinobu Akagawa, Nobuyuki Kobayashi, Ken Ohta	41
13	Chronic Thromboembolic Pulmonary Hypertension Complicated by a Cavitating Lung Infection Caused by <i>Mycobacterium intracellulare</i> 2014 ·Internal Medicine ·Kenichi Okuda, Hirotoshi Matsui, Junko Suzuki, Nobuharu Ohshima, Kimihiko Masuda, Akira Yamane, Atsuhisa Tamura, Hideaki Nagai, Shinobu Akagawa, Ken Ohta	2
14	Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: A propensity score analysis 2014 ·International Journal of Antimicrobial Agents ·Kosaku Komiya, Atsuyuki Kurashima, Toshihiko Ihi, Hideaki Nagai, Nobuhiro Matsumoto, (unknown), Hiroshi Ishii, Osamu Takahashi, Ken Ohta, Shoji Kudoh, Jun‐ichi Kadota	10
15	Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance treatment by antifungal triazoles 2014 ·Journal of Infection and Chemotherapy ·Kazuya Koyama, Nobuharu Ohshima, Junko Suzuki, Masahiro Kawashima, Keita Takeda, Takahiro Ando, Ryota Sato, Hideaki Nagai, Hirotoshi Matsui, Ken Ohta	30
16	Clinical and Microbiological Differences between Mycobacterium abscessus and Mycobacterium massiliense Lung Diseases 2012 ·Journal of Clinical Microbiology ·Toshiyuki Harada, Yasushi Akiyama, Atsuyuki Kurashima, Hideaki Nagai, Kazunari Tsuyuguchi, Takashi Fujii, (unknown), Eriko Shigeto, (unknown), Akira Kajiki, Yoshihiro Kobashi, Fumio Kokubu, (unknown), Shiomi Yoshida, Tomotada Iwamoto, Hajime Saito	131
17	Comparison of patient and family assessments of quality of life of terminally ill cancer patients in Japan 2010 ·Psycho-Oncology ·(unknown), Eisuke Matsushima, Hideaki Nagai, (unknown)	12
18	A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in healthy Japanese adults 2010 ·BMC Infectious Diseases ·Hideaki Nagai, Hideyuki Ikematsu, (unknown), Atsushi Maeda, Mamadou Dramé, François Roman	10
19	[Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis]. 2008 ·PubMed ·(unknown), Naohiro Nagayama, Yoshiko Kawabe, (unknown), Junichi Suzuki, Makiko Kunogi, Yoshinori Matsui, Masahiro Kawashima, Junko Suzuki, (unknown), (unknown), Kimihiko Masuda, Hirotoshi Matsui, Hideaki Nagai, Atsuhisa Tamura, (unknown), (unknown), Kazuko Machida, Atsuyuki Kurashima, Hideki Yotsumoto	16
20	[Secular increase in the incidence rate of drug-induced hepatitis due to anti-tuberculosis chemotherapy including isoniazid and rifampicin]. 2003 ·PubMed ·Naohiro Nagayama, Kimihiko Masuda, (unknown), Atsuhisa Tamura, Hideaki Nagai, Shinobu Akagawa, Yoshiko Kawabe, Kazuko Machida, Atsuyuki Kurashima, Hideki Yotsumoto, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact